One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-148129
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 1 |
Affiliation: Klinikum Braunschweig, Amsterdam University Medical Centers, Novartis (Switzerland), Istituti di Ricovero e Cura a Carattere Scientifico, Agostino Gemelli University Polyclinic, Tris Pharma (United States), Dana-Farber Cancer Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, University Medical Center Hamburg-Eppendorf, Autonomous University of Barcelona, Hospital de Sant Pau, University Hospital Ulm, Hospital Universitari i Politècnic La Fe, Charité - Universitätsmedizin BerlinMidostaurin in Patients (Pts) with Newly Diagnosed FLT3-Mutation Negative Acute Myeloid Leukemia (AML): Final Results and Measurable Residual Disease (MRD) Analyses from the Unify Trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
